Against the backdrop of the rising global prevalence of diabetes, safe and precise insulin delivery systems have become a focal point for pharmaceutical companies and medical institutions. Wanhai Medical has been dedicated to the research and manufacturing of insulin delivery devices for 15 years, providing comprehensive insulin injection pen solutions to global pharmaceutical companies. Our product series can perfectly adapt to various insulin formulations, including long-acting, rapid-acting, and premixed insulin, ensuring efficient drug delivery and improving patient treatment adherence.
Core Product Series:
Disposable Injection Pens: WH-DC, WH-DE
Disposable Automatic Injection Pens: WH-DG
Reusable Injection Pens: WH-RA
Wanhai insulin injection pens use a highly accurate delivery system to ensure each injection dosage is accurate and reliable: ☑ 1IU micro-adjustment mechanism to meet precise dosage needs
☑ ±3% dosing error, better than industry standards
☑ Mistouch protection to avoid incorrect dosage settings
☑ Tactile + auditory feedback for enhanced operational safety
Our injection pens are compatible with various insulin formulations of auto inject insulin pen, including:
Regular Insulin: Insulin Glargine
Rapid-acting Insulin: Insulin Aspart
Premixed Insulin: Biphasic Insulin Aspart 30/25
New Insulin Analogs: Insulin Degludec, Insulin Degludec/Liraglutide
To enhance patient experience, Wanhai injection pens feature: ✓ Ergonomically designed appearance for comfortable grip
✓ Large font dosage display convenient for elderly patients
✓ Ultra-quiet injection, reducing patient psychological burden
✓ Needle-safety design, ensuring medical personnel safety
✔ ISO 13485 certified manufacturing facility
✔ 100% full inspection + batch traceability system
✔ Compliant with USP, EP, and other pharmacopeia standards
✔ Comprehensive stability verification data
• Flexible dosage range adjustment: 0-80IU
• Personalized appearance design: brand logos, color customization
• Regulatory registration support: FDA, CE, NMPA, etc.
✓ Automated production line with an annual capacity of 90 million pens (Expansion: 300 million+)
✓ Strict supplier management system
✓ Flexible order response mechanism
✓ Global logistics distribution network
| Type of Insulin | WH-DC | WH-DE | WH-DG | WH-RA |
|---|---|---|---|---|
| Insulin Glargine | ✓ | ✓ | ✓ | ✓ |
| Insulin Aspart | ✓ | ✓ | ✓ | ✓ |
| Biphasic Insulin Aspart 30 | ✓ | ✓ | ✓ | ✓ |
| Biphasic Insulin Aspart 25 | ✓ | ✓ | ✓ | ✓ |
| NPH Insulin | ✓ | ✓ | ✓ | ✓ |
| Insulin Degludec | × | ✓ | ✓ | ✓ |
| Insulin Degludec/Liraglutide | × | ✓ | ✓ | ✓ |
Wanhai Medical provides pharmaceutical companies with:
Free sample testing
Comprehensive technical documentation support
Drug compatibility studies
Guidance for global regulatory registration
Contact Number: +86-13338192233
Business Email: sales@pen-injectors.com
Company Website: www.pen-injectors.com
Hey, I'm Mike, a R&D engineer at Wanhai Medical, and I work with injection pens every day.
In the past decade, we have provided products and integrated services to over 180 renowned pharmaceutical companies, serving clients across more than 60 countries and territories worldwide.
My days are a "battle for details". This job's meaning is in countless "gentle moments". It turns cold medical processes into warm help, easing long-term injectors' fear and boosting their confidence. Behind it all is my social responsibility, rooted in professionalism and passion: "to make sure every user is well cared for."
中文
English
français
Español
العربية
русский
